Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
May 14th, 2025
Aroa Biosurgery March Quarter Receipts Up 12%
Read More
February 19th, 2025
Aroa Biosurgery Narrowly Misses Full-Year Guidance
Read More
August 1st, 2024
Aroa Biosurgery - Moving to Cashflow Positive
Read More
November 3rd, 2023
Aroa Biosurgery – On track for Revenue of NZ$72 - NZ$75 Million
Read More
September 19th, 2023
Polynovo v AROA Biosurgery
Read More
April 6th, 2023
Aroa Biosurgery - Manufacturing Capacity to Reach NZ$150 Million
Read More
February 3rd, 2023
Aroa Biosurgery on Track with Sales and Move to Profitability
Read More
December 23rd, 2022
2023 Top Six Pick - Aroa Biosurgery: A Defensive Growth Stock for Investors
Read More
November 4th, 2022
Aroa Biosurgery - Revenue Up 44%
Read More
August 5th, 2022
Aroa Biosurgery - Cash Receipts up 162% for Quarter to NZ$13.9 Million
Read More
August 5th, 2022
Aroa Biosurgery - Cash Receipts up 162% for Quarter to NZ$13.9 Million
Read More
Pages
1
